|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1998-10-15
|
|
pubmed:abstractText |
In 1994 we started recombinant human deoxyribonuclease (rhDNase) in every cystic fibrosis (CF) patient whatever his (her) clinical condition, provided they were aged more than 5 years and forced vital capacity (FVC) was > or = 40%.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0929-693X
|
|
pubmed:author |
pubmed-author:BoutryEE,
pubmed-author:BuisineCC,
pubmed-author:DeschildreAA,
pubmed-author:DiazCC,
pubmed-author:HecquetFF,
pubmed-author:LoeuilleG AGA,
pubmed-author:LoireNN,
pubmed-author:MichaudLL,
pubmed-author:SardetAA,
pubmed-author:TassinEE,
pubmed-author:TurckDD,
pubmed-author:Wizla-DerambureNN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
378-83
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9759156-Adolescent,
pubmed-meshheading:9759156-Child,
pubmed-meshheading:9759156-Child, Preschool,
pubmed-meshheading:9759156-Cystic Fibrosis,
pubmed-meshheading:9759156-Deoxyribonuclease I,
pubmed-meshheading:9759156-Expectorants,
pubmed-meshheading:9759156-Female,
pubmed-meshheading:9759156-Forced Expiratory Volume,
pubmed-meshheading:9759156-Humans,
pubmed-meshheading:9759156-Male,
pubmed-meshheading:9759156-Nutritional Status,
pubmed-meshheading:9759156-Recombinant Proteins,
pubmed-meshheading:9759156-Retrospective Studies,
pubmed-meshheading:9759156-Spirometry,
pubmed-meshheading:9759156-Vital Capacity
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
[Effect of rhDNase on the respiratory function and nutritional status of children and adolescents with mucoviscidosis].
|
|
pubmed:affiliation |
Centre de soins pour la Mucoviscidose, Clinique de Pédiatrie, Hôpital Jeanne-de-Flandre, Lille, France.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
